The chemistry of ATP in the failing heart - The fundamentals

Heart Failure Reviews

Volumn 4, Issue 3, 1999, Pages 221-228

  Ingwall, Joanne S ^a,b   Shen, Weiqun ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

ATP; Heart failure; Phosphocreatine

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE; CREATINE KINASE; CREATINE PHOSPHATE; PURINE;

CELL KINETICS; ENERGY METABOLISM; EXPERIMENTAL MODEL; HEART FAILURE; HUMAN; NONHUMAN; PURINE SYNTHESIS; REVIEW; THERMODYNAMICS;

EID: 0033501897     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009857906567     Document Type: Review

References (36)

1. Starling RC, Hammer DF, Altschuld RA. Human myocardial ATP content and in vivo contractile function. Molec Cell Biochem 1998;180:171-177.
2. Nascimben L, Friedrich J, Liao R, Pauletto P, Pessina AC, Ingwall JS. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation 1995;91:1824-1833.
3. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res 1996;78:893-902.
4. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W, Allen PD. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 1985; 313:1050-1054.
5. Nascimben L, Ingwall JS, Pauletto P, Friedrich J, Gwathmey JK, Saks V, Pessina AC, Allen PD. Creatine kinase system in failing and nonfailing human myocardium. Circulation 1996;94:1894-1901.
6. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K. Myocardial Phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997;96:2190-2196.
7. Ingwall JS. Energetics of the normal and failing human heart: Focus on the Cr kinase reaction. In: Altschuld RA, Haworth RA, eds (Bittar E, series ed). Advances in Organ Biology: Heart Metabolism and Failure. Greenwich, CT: Jai Press Inc., 1998:117-148.
8. Tian R, Nascimben L, Kaddurah-daouk R, Ingwall JS. Depletion of energy reserve via the Cr kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol 1996;28:755-765.
9. Bottomley PA, Weiss RG. Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 1998;351:714-718.
10. Ingwall JS, Nascimben L, Gwathmey JK. Heart failure: Is the pathology due to calcium overload or to mismatch in energy supply and demand? In: Gwathmey JK, Briggs GM, Allen PD, eds. Heart Failure: Basic Science and Clinical Aspects. New York: Marcel Dekker, Inc., 1993:667-699.
11. Bittl JA, Ingwall JS. Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study. J Biol Chem 1985;260:3512-3517.
12. Tian R, Christe ME, Spindler M, Hopkins JCA, Halow JM, Camacho A, Ingwall JS. Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J Clin Invest 1997;99:745-751.
13. Goodwin GW, Taylor CS, Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem 1998;273:29530-29539.
14. Bak MI, Ingwall JS. Acidosis during ischemia promotes adenosine triphosphate resynthesis in postischemic rat heart. In vivo regulation of 5′-nucleotidase. J Clin Invest 1994;93:40-49.
15. Shen W, Asai K, Uechi M, Mathier MA, Shannon RP, Vatner SF, Ingwall JS. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs. Circulation 1999;100:2113-2118.
16. Bak MI, Ingwall JS. Regulation of cardiac AMP-specific 5′-nucleotidase during ischemia mediates ATP resynthesis on reflow. Am J Physiol 1998;274:C992-C1001.
17. Zimmer H-G, Trendelenburg C, Kammermeier H, Gerlach E. De novo synthesis of myocardial adenine nucleotides in the rat. Acceleration during recovery from oxygen deficiency. Circ Res 1973;32:635-642.
18. Morrison JF, Cleland WW. Isotype exchange studies of the mechanism of the reaction catalyzed by ATP: Creatine phosphotransferase. J Biol Chem 1966;241:673-683.
19. Shannon TR, Bers DM. Assessment of intra-SR free [Ca] and buffering in rat heart. Biophy J 1997;73:1524-1531.
20. Tian R, Ingwall JS. Energetic basis for reduced contractile reserve in isolated rat hearts. Am J Physiol 1996;270(39): H1207-H1216.
21. Bashore TM, Magorien DJ, Letterio J, Shaffer O, Unverferth DV. Histologic and biochemical correlates of left ventricular chamber dynamics in man. J Am Coll Cardiol 1987;9:734-742.
22. Regitz V, Fleck E. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 1992;69:1574-1580.
23. Bittl JA, Ingwall JS. Intracellular high-energy phosphate transfer in normal and hypertrophied myocardium. Circulation 1987;(75):I96-I101.
24. Ingwall JS. The hypertrophied myocardium accumulates the MB-creatine kinase isozyme. Eur Heart J 1984;5(F):129-139.
25. Ingwall JS, Atkinson DE, Clarke K, Fetters JK. Energetic correlates of cardiac failure: changes in the creatine kinase system in the failing myocardium. Eur Heart J 1990;11(B): 108-115.
26. Ingwall JS. Is cardiac failure a consequence of decreased energy reserve? Circulation 1993;87:VII-58-VII-62.
27. Conway MA, Allis J, Ouwerkerk R, Nhoka T, Rajagopalan B, Radda GK. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet 1991;338:973-976.
28. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 1991;122:795-801.
29. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992;86:1810-1818.
30. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97:2536-2542.
31. Schultz A, Hess T, Wevers R, Mayatepak E, Bachert P, Marescau B, Knopp MV, De Deyn PP, Bremer HJ, Rating D. Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: Diagnostic tools for a new inborn error of metabolism. J Pediatr 1997;131:626-631.
32. Seppet EK, Adoyann AJ, Kallikorm AP, Chernouska GB, Lyulina NV, Sharov VG, Sevenin VV, Popovich MI. Hormone regulation of cardiac energy metabolism. I. Creatine transport across cell membranes of euthyroid and hyperthyroid rat heart. Biochem Med 1985;34:267-279.
33. Fitch CD, Shields RP, Payne WF, Dacuse JM. Creatine metabolism in skeletal muscle. 3. Specificity of the creatine entry process. J Biol Chem 1968;243:2024-2027.
34. Loike JD, Zalutsky DL, Kaback E, Miranda AF, Silverstein SC. Extracellular creatine regulates creatine transport in rat and human muscle cells. Proc Natl Acad Sci USA 1988;85:807-811.
35. Guimbal C, Kilimann MW A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression. J Biol Chem 1993;268: 8418-8421.
36. McAuliffe JJ, Perry SB, Brooks EE, Ingwall JS. Kinetics of the creatine kinase reaction in neonatal rabbit heart: an empirical analysis of the rate equation. Biochemistry 1991;30:2585-2593.